The most striking revelation in a quarter of comments in BMJ.com on the Department of Health’s risk sharing scheme for multiple sclerosis (MS) drugs is its undermining of subseq
The new Government has promised to establish a system in which the price paid for drugs represents the value they bring to patients.
Gordon Brown’s in favour. So is the Chief Medical Officer, Sir Liam Donaldson, the Scottish National Party, Plaid Cymru, and other parties.
Of all the magnificent sleights of hand attributed to statistical science, few come close to matching the formula by which NHS funds are allocated to primary care trusts (PCTs).
Much anxiety has been caused by the publication over the past decade of hospital mortality ratios.
Back in September, I asked the Independent Safeguarding Authority how it had arrived at the figure of 11.3 million adults who would need to be vetted before they could be allowed regular access to children (their own excluded, naturally).
Reservations on today’s report by Nuffield Trust which compares funding and healthcare performance across the UK centre on: Rurality (which not even comparison between Scotland and North East England redresses), Reporting standards, Right measures, Responsiveness, and Repeat attendances.
Eight out of ten doctors are concerned about private companies profiting from the National Health Service, according to a poll from the British Medical Association and Doctors.net.uk.